COMMONS

Clinical trials

16 April 2013

The Science and Technology Committee evidence session in its inquiry into ‘Clinical trials’ on Wednesday 17 April at 9.00 a.m. has, as a result of the House agreeing to Sittings of the House (Wednesday 17 April) (Motion) on Tuesday 16 April, been rescheduled to:

Monday 22 April 2013
Committee Room 8
(to be confirmed)

At 5.15 pm

  • Catherine Elliott, Director, Clinical Research Interests, Medical Research Council
  • Sharmila Nebhrajani, Chief Executive, Association of Medical Research Charities
  • Professor Peter Johnson, Chief Clinician, Cancer Research UK
  • Representative from the Wellcome Trust;

At 6.15 pm

  • Dr Bina Rawal, Director of Research, Medical and Innovation, Association of the British Pharmaceutical Industry
  • Dr James Shannon, Chief Medical Officer, GlaxoSmithKline
  • Mr William M. Burns, Member of the Board of Directors, Roche

Further evidence sessions will be announced in due course.

Follow @CommonsSTC

Image: iStockphoto

Share this page